Table: Taisho Pharmaceutical HD -9-MTH group results
Feb 3 (Reuters)-
Taisho Pharmaceutical Holdings Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2015 Dec 31, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 224.98 221.76 290.00
(+1.5 pct) (-2.7 pct) (-0.2 pct)
Operating 22.72 24.84 27.00
(-8.5 pct) (-31.9 pct) (-15.6 pct)
Recurring 29.10 30.89 35.00
(-5.8 pct) (-29.5 pct) (-11.6 pct)
Net 18.71 19.64 21.50
(-4.8 pct) (-29.5 pct) (-12.3 pct)
EPS 230.74 yen 242.26 yen 265.23 yen
EPS Diluted 230.61 yen 242.15 yen
Ann Div 110.00 yen 100.00 yen
-Q2 div 50.00 yen 50.00 yen
-Q4 div 60.00 yen 50.00 yen
NOTE - Taisho Pharmaceutical Holdings Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10